KRAS and neoplasm: Thus, B-Raf and K-Ras mutations, which are supposed to be mutually exclusive and are both involved in the Ras-Raf-MEK-MAPK signaling pathway (MAPK, mitogen-activated protein kinase; MEK, MAPK/ERK kinase), represent early steps in tumor development [15-17].